About this trial
This study aims to evaluate whether wearable technology can improve the management of motor symptoms in people with Parkinson's disease (PD) who experience motor fluctuations throughout the day. The project will use a smartwatch and mobile app (KinesiaU) to continuously track movement, allowing for more responsive and personalized treatment compared to traditional monitoring methods.
In this pilot randomized controlled trial, 32 participants will be assigned to either:
A control group receiving standard care, or
A wearable device group receiving standard care plus using the smartwatch.
Outcomes will be assessed over a 4-week period, focusing on changes in motor function, quality of life, and self-management. The study will also examine feasibility, adherence, and data quality.
If successful, this trial will provide critical evidence for integrating wearable devices into routine clinical care for PD, paving the way for larger efficacy trials and more patient-centered care strategies.
Eligibility criteria
Qualifiers
Meet criteria for Parkinson's disease using MDS Clinical Diagnostic Criteria for Parkinson's Disease
Presence of Motor fluctuations based on movement disorder neurologist assessment.
Motor ability to use the wearable device and access the wearable device application.
Cognitively ability to do ADL's and use the wearable device and access the wearable device application based on clinician's judgment.
Disqualifiers
Physical barriers in using the wearable device.
Atypical Parkinsonian disorder or other causes of Parkinsonism
Inability to read or write English.
Trial design
Treatments tested in this trial
- Kinesia U
- Standard of care treatment
Treatment groups
Sponsors and collaborators
Western University
Lead sponsor
Academic Medical Organization of Southwestern Ontario
Collaborator